Beijing, China

Jingwang Fan

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jingwang Fan. Retrieved from https://idiyas.com/inventor/jingwang-fan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jingwang Fan in Pharmaceutical Research

Introduction

Jingwang Fan is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of prodrug compounds. His work focuses on enhancing the solubility and pharmacokinetic profiles of existing medications.

Latest Patents

Jingwang Fan holds a patent for a prodrug compound of levosimendan, which includes a preparation method and its uses. This invention addresses the limitations of levosimendan, such as poor water solubility. The prodrug compound is designed to improve the pharmacokinetic profile and has promising prospects for medicinal development.

Career Highlights

Fan is associated with the Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd. His work at this institute has allowed him to explore innovative solutions in drug formulation and development. His research has the potential to impact the pharmaceutical industry positively.

Collaborations

Jingwang Fan collaborates with esteemed colleagues, including Shaolin Huang and Changbin Guo. These partnerships enhance the research and development efforts within the institute, fostering a collaborative environment for innovation.

Conclusion

Jingwang Fan's contributions to pharmaceutical research, particularly through his patent on levosimendan prodrug compounds, highlight his role as an innovator in the field. His work promises to advance medication development and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…